Fred R Hirsch

11PUBLICATIONS
84CO-AUTHORS
Solid tumoursMolecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Dec 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Kristiina Boettiger, Ildikó Kovács, Lilla Horvath

|Jun 04, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|Apr 28, 2025
Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Where Are the Target and the Biomarker?

Fred R Hirsch

|Jan 06, 2025
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions.

Yibei Wang, Mohammed Safi, Fred R Hirsch

Pageof 2